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Finding a Way through the Pathways
PAGE 629
Genomic DNA sequencing provides ready access to a list of all human proteins. D’Eustachio discusses how pathway
databases in turn systematically associate these proteins with their functions, linking them into the human reaction
space, using The Reactome Knowledgebase to illustrate strategies used to assemble it.Special Issue: Perspective
Metagenomic Digging for Bacterial Biosynthetic Gold
PAGE 636
The vast majority of bacteria remains uncultivated in the laboratory and is
hypothesized to represent a virtually untapped resource for new bio-
catalysts and natural products. Wilson and Piel highlight the role of meta-
genomics in accessing natural products and their biosynthetic machinery
from uncultivated bacteria.Special Issue: Perspective
Secrets of the DNA-damaging Agents
PAGE 648
DNA-damaging agents are a mainstay of cancer chemotherapy, yet the
full spectrum of their mechanism of action is not known. Cheung-Ong
et al. discuss existing and new DNA-damaging agents, comment on their
limitations, and describe the potential of chemical genomics to charac-
terize these drugs at the systems level.Special Issue: Review
iPOP to Your Health
PAGE 660
The growing importance of understanding health states in flux is beneficial for improved health care. Li-Pook-Than and
Snyder review how integrated personal omics profiling (iPOP), the overlaying of personal genome with various omic
analyses, gives a better assessment of individual’s health, and how iPOP may be used.Special Issue: Review
Entering the Protein-Small Molecule Universe
PAGE 667
Interactions between small molecules and proteins are ubiquitous and
drive the function in biological systems. McFedries et al. review recent
advancements in methodologies for identifying protein-small molecule
and protein-metabolite interactions.Special Issue: Review
Structural Systems Pharmacology
PAGE 674
As a part of the special issue, Duran-Frigola et al. review some recent
advances in the structural annotation of cell networks and discuss their
potential impact on some of the hottest areas of drug development,
from the targeting of allosteric sites to their potential impact in personal-
ized medicine.Chemistry & Biology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reserved ix
Chemistry & Biology
In This IssueSpecial Issue: Review
Microarrays for Proteomics
PAGE 685
Microarrays are a prominent technology in proteomics that have brought tremendous progress to life sciences
and biomedical research. Sun and Yao review the most recent advancement in peptide, small molecule, and protein
microarray technologies, and elaborate on their advantages, challenges, and future directions.Inhibit Arp2/3 Complex
PAGE 701
The Arp 2/3 complex nucleates branched actin filaments important for many cellular functions. Hetrick et al. determine
the mechanism of CK-666 and CK-869 and show they inhibit Arp2/3 complex by blocking an activating conformational
change that is induced by nucleation promoting factors and actin monomer binding.x Chemistry & Biology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reservedHitting HDAC1/HDAC2 in
Neuroblastoma
PAGE 713
New approaches are needed to treat
childhood malignancies such as
neuroblastoma. Frumm et al. show
that histone deacetylase (HDAC)
inhibition with HDAC1/HDAC2 selec-
tive molecules combined with 13-cis
retinoic acid, a drug already in use,
exhibited improved therapeutic po-
tential in neuroblastoma.DNA Doing Long Divisions
PAGE 726Ratner et al. presents experimental realization of a DNA-based transducer that not
only computes iteratively, but also produces biologically relevant results. The
transducer was employed to solve a specific problem of a long division of binary
numbers by 3, but the methodology is generally applicable.Resources
Mining the Antibody Library
PAGE 734
Zhang et al. report a powerful method for the generation of new agonists to
virtually any receptor that couples the massive diversity of human combinatorial
antibody libraries to phenotypic screens. Thismakes each cell a screening system
unto itself and allows analysis of two million events an hour.
